Company intelligence / Profile preview

Visikol

Hampton, New Jersey, United Statesvisikol.com ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

Visikol is an active contract research organization specializing in advanced tissue imaging, multiplex tissue imaging, digital pathology, and 2D/3D cell culture assays to accelerate drug discovery and development for pharmaceutical and biotech clients. The company is recognized for its expertise in transforming tissues into actionable data using cutting-edge imaging technologies. It was acquired by BICO.

Industry: Drug Discovery Services

Partnerships

Standard BioTools (for Imaging Mass Cytometry service offering)

Beyond the preview

Go deeper on Visikol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visikol.

Explore the full profile